Monoclonal Antibody Therapy
Experienced Infusion Team
Our experienced infusion team is currently working with Bamlanivimab, a Monoclonal Antibody Therapy. This therapy was approved by the FDA under an Emergency Use Authorization to treat COVID-19.
We Handle The Details
We provide the procedures and documentation. We’ll coordinate the arrival of the medication with your pharmacy. Our clinical team will monitor the patient for the duration of the treatment, and manage any reactions that may occur. Finally, we’ll do the documentation and reporting, if necessary. This is an all-inclusive program that can make this new therapy available to your patients as soon as possible.